.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Argus Health
Merck
Healthtrust
UBS
Novartis
Chubb
Cantor Fitzgerald
McKinsey

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040246

« Back to Dashboard
NDA 040246 describes COMPRO, which is a drug marketed by Paddock Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the COMPRO profile page.

The generic ingredient in COMPRO is prochlorperazine. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.

Summary for NDA: 040246

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040246

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 040246

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COMPRO
prochlorperazine
SUPPOSITORY;RECTAL 040246 ANDA Paddock Laboratories, LLC 0574-7226 0574-7226-12 12 PACKET in 1 CARTON (0574-7226-12) > 1 SUPPOSITORY in 1 PACKET
COMPRO
prochlorperazine
SUPPOSITORY;RECTAL 040246 ANDA PD-Rx Pharmaceuticals, Inc. 55289-119 55289-119-02 2 SUPPOSITORY in 1 BOTTLE, PLASTIC (55289-119-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUPPOSITORY;RECTALStrength25MG
Approval Date:Jun 28, 2000TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Novartis
Dow
Medtronic
Citi
Daiichi Sankyo
QuintilesIMS
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot